Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice Study
2003; Lippincott Williams & Wilkins; Volume: 169; Issue: 1 Linguagem: Inglês
10.1016/s0022-5347(05)64051-7
ISSN1527-3792
AutoresJoseph C. Presti, Gerard J. O’Dowd, M. Craig Miller, Rubina Mattu, Robert W. Veltri,
Tópico(s)Urologic and reproductive health conditions
ResumoNo AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Jan 2003Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice Study JOSEPH C. PRESTI, GERARD J. O’DOWD, M. CRAIG MILLER, RUBINA MATTU, and ROBERT W. VELTRI JOSEPH C. PRESTIJOSEPH C. PRESTI More articles by this author , GERARD J. O’DOWDGERARD J. O’DOWD More articles by this author , M. CRAIG MILLERM. CRAIG MILLER More articles by this author , RUBINA MATTURUBINA MATTU More articles by this author , and ROBERT W. VELTRIROBERT W. VELTRI More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64051-7AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We assessed the impact of age and prostate specific antigen (PSA) on extended systematic biopsy schemes for detecting prostate carcinoma and better characterized these tumors as a function of patient age and PSA. Materials and Methods: We retrospectively reviewed the records of 2,299 consecutive patients who underwent initial systematic biopsy performed by 167 community based urologists. A total of 12 systematic biopsies of the peripheral zone were obtained in all patients. Various biopsy schemes were then created and cancer detection rates were calculated. Data analyses were stratified by patient age and PSA. Results: On biopsy 1,020 patients (44.4%) had cancer. Detection rates increased with increasing patient age. Increasing age and PSA were associated with larger, higher grade tumors. Overall and unique site specific cancer detection rates were highest for laterally directed biopsies and the apical biopsy of the standard sextant scheme. The 12 site biopsy scheme outperformed all other schemes in patients with PSA 7 ng./ml. or less and in those 60 years or younger. The variation in age related and PSA related detection rates was greatest for the standard sextant scheme and this variability decreased for extended biopsy schemes. Conclusions: This multi-practice community based study confirms the inadequacy of sextant biopsies and emphasizes the need for extended peripheral zone sampling of the lateral aspect of the prostate. Generally increasing patient age and PSA were associated with larger, higher grade tumors. Extended biopsy schemes minimize PSA and age related detection rates. References 1 : The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology1997; 50: 562. Crossref, Medline, Google Scholar 2 : Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol1998; 159: 1247. Link, Google Scholar 3 : Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol1997; 157: 199. Link, Google Scholar 4 : The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol2000; 163: 163. Link, Google Scholar 5 : Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol2001; 165: 1554. Link, Google Scholar 6 : Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol1988; 12: 897. Crossref, Medline, Google Scholar 7 : Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology1998; 51: 186. Crossref, Medline, Google Scholar 8 : Effect of aging on morphologic and clinical predictors of prostate cancer progression. Prostate J2000; 3: 157. Crossref, Google Scholar From the Department of Urology, Stanford University School of Medicine, Stanford, California, UroCor Laboratories, Dianon Systems and Department of Pathology, Oklahoma University Health Science Center, Oklahoma City, Oklahoma© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Zhang C, Tu X, Dai J, Xiong X, Cai D, Yang L, Zhang M, Qiu S, Lin T, Liu Z, Yang L and Wei Q (2023) Efficacy and safety of the new biopsy strategy combining 6-core systematic and 3-core MRI-targeted biopsy in the detection of prostate cancer: Study protocol for a randomized controlled trialFrontiers in Surgery, 10.3389/fsurg.2022.1058288, VOL. 9 Ou W, Lei J, Li M, Zhang X, Liang R, Long L, Wang C, Chen L, Chen J, Zhang J and Wang Z (2022) Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsiesThe Prostate, 10.1002/pros.24442, VOL. 83, NO. 1, (109-118), Online publication date: 1-Jan-2023. Jinxing Y, Ugo F, Sarah G W, Kendal A, Ann S F, Mary A T, Sterling J, Rohan K and Steven C S (2022) Comparison of Gleason score of Prostate Cancer at Ultrasound/MRI Fusion Target Biopsy vs. Systematic Transrectal Ultrasound Guided Biopsy with Final Gleason score at Radical ProstatectomyArchive of Urological Research, 10.17352/aur.000039, VOL. 6, NO. 2, (017-021) Liu Y, Zeng S and Xu R (2022) Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate CancerFrontiers in Oncology, 10.3389/fonc.2022.905087, VOL. 12 Schaufler C, Daigle R, Singhaviranon S, Gjertson C, Albertsen P and Ristau B (2022) How many cores are enough? Optimizing the transperineal prostate biopsy templateUrologic Oncology: Seminars and Original Investigations, 10.1016/j.urolonc.2021.11.026, VOL. 40, NO. 5, (191.e1-191.e7), Online publication date: 1-May-2022. Steiner A, Schmidt S, Fellmann C, Nowak J, Wu C, Feldman A, Beer M and Cheng L (2022) Ex Vivo High-Resolution Magic Angle Spinning (HRMAS) 1H NMR Spectroscopy for Early Prostate Cancer DetectionCancers, 10.3390/cancers14092162, VOL. 14, NO. 9, (2162) Cheng E, Davuluri M, Lewicki P, Hu J and Basourakos S (2021) Developments in optimizing transperineal prostate biopsyCurrent Opinion in Urology, 10.1097/MOU.0000000000000947, VOL. 32, NO. 1, (85-90), Online publication date: 1-Jan-2022. Altok M, Demirel C, Kang H, Choi H, John D, Inguillo I, Davis J and Ward J (2021) Impact of MRI/US fusion‐guided prostate biopsy on biopsy‐naïve patients: A single urologist’s experienceBJUI Compass, 10.1002/bco2.86, VOL. 3, NO. 1, (19-25), Online publication date: 1-Jan-2022. Kawa S, Stroomberg H, Larsen S, Helgstrand J, Toft B, Brasso K and Røder M (2021) Detection of Clinically Significant Prostate Cancer by Systematic TRUS-Biopsies in a Population-Based Setting Over a 20 Year PeriodUrology, 10.1016/j.urology.2021.06.007, VOL. 155, (20-25), Online publication date: 1-Sep-2021. Chung J, Kim H, Ha Y, Lee E, Chun S, Lee C, Byeon K, Choi S, Lee J, Kim B, Kim T, Yoo E, Yoon G, Baek M, Kwon T and Teoh J (2021) Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 proteinPLOS ONE, 10.1371/journal.pone.0250254, VOL. 16, NO. 4, (e0250254) Lee D, Chung B and Lee K (2021) Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation systemInvestigative and Clinical Urology, 10.4111/icu.20210060, VOL. 62, NO. 6, (658), . Kocan H (2019) Factors affecting the diagnosis of prostate cancer through 12 quadrant guided prostate biopsyThe Aging Male, 10.1080/13685538.2019.1573219, VOL. 23, NO. 5, (663-668), Online publication date: 4-Dec-2020. Kulkarni P, Sikander S, Biswas P, Laha S, Cornnell H, Burt J, Bagci U and Song S (2020) Development of a Device-to-Image Registration Free Needle Guide for Magnetic Resonance Imaging-Guided Targeted Prostate BiopsyJournal of Medical Devices, 10.1115/1.4047874, VOL. 14, NO. 4, Online publication date: 1-Dec-2020. Doménech-Carbó A, Doménech-Casasús C, Pontones J and Ramos D (2020) Biomedical application of VIMP: screening of malignant cells in the prostateJournal of Solid State Electrochemistry, 10.1007/s10008-020-04638-7, VOL. 24, NO. 11-12, (2853-2860), Online publication date: 1-Nov-2020. Ippolito D, Querques G, Pecorelli A, Perugini G, Roscigno M, Da Pozzo L, Maino C and Sironi S (2020) Diagnostic accuracy of multiparametric magnetic resonance imaging combined with clinical parameters in the detection of clinically significant prostate cancer: A novel diagnostic modelInternational Journal of Urology, 10.1111/iju.14316, VOL. 27, NO. 10, (866-873), Online publication date: 1-Oct-2020. Alshehri S, Alshahrani O, Almsaoud N, Al-Ghamdi M, Alqahtani A, Almurayyi M, Autwdi A, Al-Ghamdi S, Zogan M and Alamri A (2020) The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic reviewAnnals of Medicine and Surgery, 10.1016/j.amsu.2020.07.015, VOL. 57, (171-178), Online publication date: 1-Sep-2020. Gavin D, Kam J, Krelle M, Louie-Johnsun M, Sutherland T, Koschel S, Jenkins M, Yuminaga Y, Kim R, Aluwihare K, Skinner S, Brennan J and Wong L (2020) Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre StudyEuropean Urology Open Science, 10.1016/j.euros.2020.07.001, VOL. 20, (28-36), Online publication date: 1-Jul-2020. Swersey A, Colberg J, Evans R, Kattan M, Ledolter J and Parker R (2019) Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes’ Theorem to reduce costs and improve outcomesHealth Care Management Science, 10.1007/s10729-019-09480-6, VOL. 23, NO. 1, (102-116), Online publication date: 1-Mar-2020. De Nunzio C, Tema G, Trucchi A, Cicione A, Sica A, Lombardo R and Tubaro A Smoking reduces PSA accuracy for detection of prostate cancer: results from an Italian cross-sectional studyMinerva Urologica e Nefrologica, 10.23736/S0393-2249.19.03360-5, VOL. 71, NO. 6 Salji M, Ahmad I, Slater S, Poon F, Alhasso A, Melquiot N, Bekarma H, Hendry J and Leung H (2019) Prostate Neoplasm Blandy's Urology, 10.1002/9781118863343.ch28, (563-609), Online publication date: 22-Mar-2019. Sun Y, Reynolds H, Parameswaran B, Wraith D, Finnegan M, Williams S and Haworth A (2019) Multiparametric MRI and radiomics in prostate cancer: a reviewAustralasian Physical & Engineering Sciences in Medicine, 10.1007/s13246-019-00730-z, VOL. 42, NO. 1, (3-25), Online publication date: 1-Mar-2019. Ha H, Chung J, Ha Y, Choi S, Lee J, Kim B, Kim H, Kim T, Yoon G, Kwon T, Chung S and Yoo E (2019) Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsyInvestigative and Clinical Urology, 10.4111/icu.2019.60.6.447, VOL. 60, NO. 6, (447), . Shah R and Zhou M (2019) Needle Biopsy Sampling Techniques and Role of Multiparametric-Magnetic Resonance Imaging Modality in Prostate Cancer Diagnosis and Management Prostate Biopsy Interpretation, 10.1007/978-3-030-13601-7_2, (11-17), . De Nunzio C, Tema G, Lombardo R, Trucchi A, Bellangino M, Esperto F, Deroma M, Proietti F, Vecchione A and Tubaro A Cigarette smoking is not associated with prostate cancer diagnosis and aggressiveness: a cross sectional Italian studyMinerva Urologica e Nefrologica, 10.23736/S0393-2249.18.03182-X, VOL. 70, NO. 6 Ortelli L, Spitale A, Mazzucchelli L and Bordoni A (2018) Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern SwitzerlandBMC Cancer, 10.1186/s12885-018-4604-2, VOL. 18, NO. 1, Online publication date: 1-Dec-2018. Ristau B, Allaway M, Cendo D, Hart J, Riley J, Parousis V and Albertsen P (2018) Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector templateUrologic Oncology: Seminars and Original Investigations, 10.1016/j.urolonc.2018.09.013, VOL. 36, NO. 12, (528.e15-528.e20), Online publication date: 1-Dec-2018. Behrens S, Kachanov M and Budäus L (2018) Ein neuer Goldstandard der Prostatakarzinomdiagnostik?Un nouveau standard de référence dans le diagnostic du cancer de la prostate?Journal für Urologie und Urogynäkologie/Schweiz, 10.1007/s41973-018-0037-4, VOL. 20, NO. 4, (121-127), Online publication date: 1-Dec-2018. Behrens S, Kachanov M and Budäus L (2018) Ein neuer Goldstandard der Prostatakarzinomdiagnostik?A new gold standard of prostate cancer diagnostics?Journal für Urologie und Urogynäkologie/Österreich, 10.1007/s41972-018-0053-z, VOL. 25, NO. 4, (152-159), Online publication date: 1-Dec-2018. Sathianathen N, Konety B, Crook J, Saad F and Lawrentschuk N (2018) Landmarks in prostate cancerNature Reviews Urology, 10.1038/s41585-018-0060-7, VOL. 15, NO. 10, (627-642), Online publication date: 1-Oct-2018. Ziaei A (2018) Advances in Medical Imaging Technology for Accurate Detection of Prostate Cancer Prostate Cancer, 10.5772/intechopen.77327 De Nunzio C, Brassetti A, Simone G, Lombardo R, Mastroianni R, Collura D, Muto G, Gallucci M and Tubaro A (2018) Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort studyProstate Cancer and Prostatic Diseases, 10.1038/s41391-018-0054-9, VOL. 21, NO. 3, (438-445), Online publication date: 1-Sep-2018. De Nunzio C, Lombardo R, Tema G, Alkhatatbeh H, Gandaglia G, Briganti A and Tubaro A (2018) External validation of Chun, PCPT, ERSPC, Kawakami, and Karakiewicz nomograms in the prediction of prostate cancer: A single center cohort-studyUrologic Oncology: Seminars and Original Investigations, 10.1016/j.urolonc.2018.05.010, VOL. 36, NO. 8, (364.e1-364.e7), Online publication date: 1-Aug-2018. De Nunzio C, Lombardo R, Nacchia A, Tema G and Tubaro A (2018) Repeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancerBJU International, 10.1111/bju.14197, VOL. 122, NO. 1, (83-88), Online publication date: 1-Jul-2018. Tavolaro S, Mozer P, Roupret M, Comperat E, Rozet F, Barret E, Drouin S, Vaessen C, Lucidarme O, Cussenot O, Boudghène F and Renard-Penna R (2018) Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsyDiagnostic and Interventional Imaging, 10.1016/j.diii.2018.01.006, VOL. 99, NO. 6, (403-411), Online publication date: 1-Jun-2018. Miller E, Salmasi A and Reiter R (2017) Anatomic and Molecular Imaging in Prostate CancerCold Spring Harbor Perspectives in Medicine, 10.1101/cshperspect.a030619, VOL. 8, NO. 3, (a030619), Online publication date: 1-Mar-2018. Heo J, Koo K, Hong S, Park S, Chung B and Lee K (2018) Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate BiopsyYonsei Medical Journal, 10.3349/ymj.2018.59.2.219, VOL. 59, NO. 2, (219), . Morlacco A, Murphy C, Rangel L, Mynderse L, Thompson R and Karnes R (2016) Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy SpecimenUrology Practice, VOL. 5, NO. 1, (76-82), Online publication date: 1-Jan-2018. Mariotti G, Falsarella P, Garcia R, Queiroz M, Lemos G and Baroni R (2017) Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled studyEuropean Radiology, 10.1007/s00330-017-4939-0, VOL. 28, NO. 1, (11-16), Online publication date: 1-Jan-2018. Postema A, Scheltema M, Mannaerts C, Van Sloun R, Idzenga T, Mischi M, Engelbrecht M, De la Rosette J and Wijkstra H (2017) The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patientsBMC Urology, 10.1186/s12894-017-0213-7, VOL. 17, NO. 1, Online publication date: 1-Dec-2017. Olson M, Atwell T, Mynderse L, King B, Welch T and Goenka A (2016) CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experienceEuropean Radiology, 10.1007/s00330-016-4694-7, VOL. 27, NO. 8, (3326-3332), Online publication date: 1-Aug-2017. Liehr U, Baumunk D, Blaschke S, Fischbach F, Friebe B, König F, Lemke A, Mittelstädt P, Pech M, Porsch M, Ricke J, Schindele D, Siedentopf S, Wendler J and Schostak M (2017) Die Vorsteherdrüse – was möchte der Urologe vom Radiologen wissen?Prostate gland – what would urologists like to know from radiologists?Der Radiologe, 10.1007/s00117-017-0273-4, VOL. 57, NO. 8, (608-614), Online publication date: 1-Aug-2017. Shakir N, Rais-Bahrami S and Pinto P (2017) Biopsy Strategies in the Analysis of Urologic Neoplasia Management of Urologic Cancer, 10.1002/9781118868126.ch6, (83-112) Song P and Ko Y (2017) Lateral decubitus position vs. lithotomy position: which is the best way to minimize patient’s pain perception during transrectal prostate biopsy?International braz j urol, 10.1590/s1677-5538.ibju.2015.0479, VOL. 43, NO. 3, (462-469), Online publication date: 1-Jun-2017. Pan Y, Liu B, Huang Y, Wang J, Li X, Zhang C, Wu J, Zheng Y, Qin C, Cheng G, Hua L and Wang Z (2017) Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methodsOncotarget, 10.18632/oncotarget.16512, VOL. 8, NO. 20, (32930-32936), Online publication date: 16-May-2017. Schieda N, Lim C, Idris M, Lim R, Morash C, Breau R, Flood T and McInnes M (2016) MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysisJournal of Magnetic Resonance Imaging, 10.1002/jmri.25510, VOL. 45, NO. 5, (1296-1303), Online publication date: 1-May-2017. Carneiro A, Sivaraman A, Sanchez-Salas R, Nunes-Silva I, Baghdadi M, Srougi V, di Trapani E, Pizzaro F, Doizi S, Barret E, Rozet F, Galiano M and Cathelineau X (2017) Higher number of transrectal ultrasound guided prostate biopsy cores is associated with higher blood loss and perioperative complications in robot assisted radical prostatectomyActas Urológicas Españolas (English Edition), 10.1016/j.acuroe.2017.02.003, VOL. 41, NO. 3, (155-161), Online publication date: 1-Apr-2017. Carneiro A, Sivaraman A, Sanchez-Salas R, Nunes-Silva I, Baghdadi M, Srougi V, di Trapani E, Uriburu Pizzaro F, Doizi S, Barret E, Rozet F, Galiano M and Cathelineau X (2017) Un mayor número de cilindros de biopsia transrectal de próstata guiada por ultrasonido se asocia con una mayor pérdida de sangre y complicaciones perioperatorias en la prostatectomía radical asistida por robotActas Urológicas Españolas, 10.1016/j.acuro.2016.09.012, VOL. 41, NO. 3, (155-161), Online publication date: 1-Apr-2017. Fei B, Nieh P, Master V, Zhang Y, Osunkoya A and Schuster D (2016) Molecular imaging and fusion targeted biopsy of the prostateClinical and Translational Imaging, 10.1007/s40336-016-0214-7, VOL. 5, NO. 1, (29-43), Online publication date: 1-Feb-2017. Franz T, von Hardenberg J, Blana A, Cash H, Baumunk D, Salomon G, Hadaschik B, Henkel T, Herrmann J, Kahmann F, Köhrmann K, Köllermann J, Kruck S, Liehr U, Machtens S, Peters I, Radtke J, Roosen A, Schlemmer H, Sentker L, Wendler J, Witzsch U, Stolzenburg J, Schostak M and Ganzer R (2016) MRT/TRUS-fusionierte BiopsiesystemeMRI/TRUS fusion-guided prostate biopsyDer Urologe, 10.1007/s00120-016-0268-1, VOL. 56, NO. 2, (208-216), Online publication date: 1-Feb-2017. Jiang X, Zhang J, Tang J, Xu Z, Zhang W, Zhang Q, Guo H and Zhou W (2016)(2016) Magnetic resonance imaging - ultrasound fusion targeted biopsy outperforms standard approaches in detecting prostate cancer: A meta-analysisMolecular and Clinical Oncology, 10.3892/mco.2016.906, VOL. 5, NO. 2, (301-309), Online publication date: 1-Aug-2016. De Nunzio C, Presicce F, Lombardo R, Cancrini F, Petta S, Trucchi A, Gacci M, Cindolo L and Tubaro A (2015) Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysisBJU International, 10.1111/bju.13157, VOL. 117, NO. 6B, (E29-E35), Online publication date: 1-Jun-2016. Moosavi B, Flood T, Al-Dandan O, Breau R, Cagiannos I, Morash C, Malone S and Schieda N (2016) Multiparametric MRI of the anterior prostate gland: clinical–radiological–histopathological correlationClinical Radiology, 10.1016/j.crad.2016.01.002, VOL. 71, NO. 5, (405-417), Online publication date: 1-May-2016. Yazici S, Kiziloz H, Bozaci A, Baydar D, Del Biondo D and Ozen H (2015) Predictors of Prostate Cancer in Ultrasound-Guided Transperineal Saturation Biopsy in Turkish Men with Multiple Prior Negative BiopsiesUrologia Journal, 10.5301/uro.5000159, VOL. 83, NO. 2, (71-76), Online publication date: 1-Apr-2016. Seles M, Gutschi T, Mayrhofer K, Fischereder K, Ehrlich G, Gallé G, Gutschi S, Pachernegg O, Pummer K and Augustin H (2015) Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostateBJU International, 10.1111/bju.13108, VOL. 117, NO. 4, (592-597), Online publication date: 1-Apr-2016. Gordetsky J, Nix J and Rais-Bahrami S (2016) Perineural Invasion in Prostate Cancer Is More Frequently Detected by Multiparametric MRI Targeted Biopsy Compared With Standard BiopsyAmerican Journal of Surgical Pathology, 10.1097/PAS.0000000000000546, VOL. 40, NO. 4, (490-494), Online publication date: 1-Apr-2016. Mazzocco C, Fracasso G, Germain-Genevois C, Dugot-Senant N, Figini M, Colombatti M, Grenier N and Couillaud F (2016) In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probeScientific Reports, 10.1038/srep23314, VOL. 6, NO. 1 De Nunzio C, Truscelli G, Trucchi A, Petta S, Tubaro M, Gacci M, Gaudio C, Presicce F and Tubaro A (2015) Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysisProstate Cancer and Prostatic Diseases, 10.1038/pcan.2015.45, VOL. 19, NO. 1, (35-39), Online publication date: 1-Mar-2016. Dulaney C, Osula D, Yang E and Rais-Bahrami S (2016) Prostate Radiotherapy in the Era of Advanced Imaging and Precision MedicineProstate Cancer, 10.1155/2016/4897515, VOL. 2016, (1-10), . Hosein I, Sukhraj R, Goetz L, Rambarran N and Persaud S (2016) A Clinicopathological Profile of Prostate Cancer in Trinidad and TobagoAdvances in Urology, 10.1155/2016/2075021, VOL. 2016, (1-5), . Mendhiratta N and Taneja S (2016) Focal Therapy for Prostate Cancer Prostate Cancer, 10.1016/B978-0-12-800077-9.00060-8, (563-577), . Leapman M and Shinohara K (2016) TRUS Biopsy: Is There Still a Role? The Prostate Cancer Dilemma, 10.1007/978-3-319-21485-6_4, (53-67), . Schoots I, Roobol M, Nieboer D, Bangma C, Steyerberg E and Hunink M (2015) Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysisEuropean Urology, 10.1016/j.eururo.2014.11.037, VOL. 68, NO. 3, (438-450), Online publication date: 1-Sep-2015. Quon J, Moosavi B, Khanna M, Flood T, Lim C and Schieda N (2015) False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillanceInsights into Imaging, 10.1007/s13244-015-0411-3, VOL. 6, NO. 4, (449-463), Online publication date: 1-Aug-2015. Valette T, Antunes A, Leite K and Srougi M (2015) Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate CancerInternational braz j urol, 10.1590/S1677-5538.IBJU.2014.0223, VOL. 41, NO. 3, (449-454) Hong C, Rais-Bahrami S, Walton-Diaz A, Shakir N, Su D, George A, Merino M, Turkbey B, Choyke P, Wood B and Pinto P (2014) Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approachesBJU International, 10.1111/bju.12871, VOL. 115, NO. 5, (772-779), Online publication date: 1-May-2015. ElShafei A, Kartha G, Hatem A, Neifert H and Jones J (2015) Transrectal Saturation Biopsy Improves Risk Stratification (Reclassification) of Patients with Prostate Cancer on Active SurveillanceUrology Practice, VOL. 2, NO. 3, (115-120), Online publication date: 1-May-2015. Zhang Q, Wang W, Yang R, Zhang G, Zhang B, Li W, Huang H and Guo H (2015) Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in ChinaInternational Urology and Nephrology, 10.1007/s11255-015-0957-5, VOL. 47, NO. 5, (727-733), Online publication date: 1-May-2015. Kwak J, Xu S, Wood B, Turkbey B, Choyke P, Pinto P, Wang S and Summers R (2015) Automated prostate cancer detection using T 2-weighted and high- b -value diffusion-weighted magnetic resonance imaging Medical Physics, 10.1118/1.4918318, VOL. 42, NO. 5, (2368-2378), Online publication date: 16-Apr-2015. Huh J, Kim
Referência(s)